Business & Finance
The Rudd Report updates research on AMDL's activities in the China pharmaceutical market
Published in Cancer Weekly, December 26th, 2006
The report said that China is developing a new and massive middle class, whose spending power will redefine the Chinese market. "These working consumers, once the country's poorest, will steadily climb the income ladder, with the result that hundreds of millions of households will enter the country's middle class. While some companies are already focusing on this evolution, many others have yet to broaden their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-12-26)
More Articles from Cancer Weekly
- Clinical Trials
Immunicon to conduct circulating tumor cell testing for breast cancer clinical trial - Cancer Gene Therapy
Investigators at University of Colorado, Colorado Cancer Center have published new data on cancer gene therapy - Cancer Gene Therapy
Korea Institute of Radiological and Medical Science details research in cancer gene therapy - Cancer Gene Therapy
New cancer gene therapy research from Georgetown University, Lombardi Comprehensive Cancer Center outlined - Cancer Gene Therapy
New cancer gene therapy study findings recently were published by researchers at Okayama University - Cancer Gene Therapy
New cancer gene therapy study results from Center for Cancer Research described - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
